ATG-Fresenius increases the risk of red blood cell transfusion after kidney transplantation

INTRODUCTION: In sensitized deceased donor kidney allograft recipients, the most frequent induction therapy is anti-thymocyte globulins (ATG), including Thymoglobulin® (Thymo) and ATG-Fresenius (ATG-F). METHODS: We conducted a 3-year monocentric observational study to compare the impact of ATGs on h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebti, Maria, Petit-Hoang, Camille, Chami, Btissam, Audureau, Étienne, Cordonnier-Jourdin, Catherine, Paul, Muriel, Pourcine, Franck, Grimbert, Philippe, Ourghanlian, Clément, Matignon, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753326/
https://www.ncbi.nlm.nih.gov/pubmed/36532030
http://dx.doi.org/10.3389/fimmu.2022.1045580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753326/
https://www.ncbi.nlm.nih.gov/pubmed/36532030
http://dx.doi.org/10.3389/fimmu.2022.1045580

Ejemplares similares